LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_058216.3:c.571+15G>T
RAD51C
· NP_478123.1:p.?
· NM_058216.3
GRCh37: chr17:56774235 G>T
·
GRCh38: chr17:58696874 G>T
Gene:
RAD51C
Transcript:
NM_058216.3
Final call
VUS
PM2 supporting
BP4 supporting
Variant details
Gene
RAD51C
Transcript
NM_058216.3
Protein
NP_478123.1:p.?
gnomAD AF
1.611725426456349e-05 (v4.1)
ClinVar
Likely benign
OncoKB
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM2 (supporting, pathogenic direction): gnomAD v4.1 allele frequency 0.0000161 (26/1,613,178; grpmax FAF 0.0000138) sits below the 0.0001 rarity threshold.
2
BP4 (supporting, benign direction): SpliceAI max delta 0.006 predicts no impact on splicing in this intronic variant.
3
Not applied: PVS1 not applicable (non-canonical intronic change, no null-variant class, no splice effect), BA1/BS1/BS2 not met (frequency far below thresholds), PP5/BP6 not met (no expert-panel assertion), PM1/PM3/PM4/PM5/PP2/BP1/BP2/BP3/BP7 not met or not applicable.
Final determination:
Under the generic ACMG/AMP 2015 combination rules no pathogenic combination is reached (no PVS1, PS or >=2 PM criteria; only one supporting-level PM2) and no benign or likely-benign combination is reached (no BA1, no BS criterion, and a single supporting BP4 does not satisfy the 2-BP rule), so the one pathogenic-direction and one benign-direction supporting criteria conflict and the variant is classified Variant of Uncertain Significance.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: c.571+15G>T is a deep intronic non-canonical variant (SpliceAI max delta 0.006), not a null variant, and no RNA evidence exists. |
cspec
spliceai
pvs1_generic_framework
PMID:25741868
|
| PS1 | N/A | Not applicable: c.571+15G>T is intronic with predicted consequence p.?, so it produces no amino-acid change to match against an established pathogenic variant. |
cspec
PMID:25741868
PMID:25394175
|
| PS2 | Not assessed | Not assessed: no proband and no parental/trio testing data exist in this case, so a confirmed de novo occurrence cannot be evaluated. |
cspec
PMID:25741868
clinvar
|
| PS3 | Not assessed | Not assessed: no RNA or protein functional assay has been reported for RAD51C c.571+15G>T, so PS3 has no assay evidence. |
PMID:25741868
cspec
clinvar
|
| PS4 | Not assessed | Not assessed: no case-control data or affected probands exist for c.571+15G>T, so no enrichment statistic could be compared. |
clinvar
cspec
PMID:20301575
PMID:25394175
PMID:25741868
PMID:28492532
|
| PM1 | Not met | Not met: c.571+15G>T is intronic (intron 3, p.?) with no residue inside any RAD51C critical domain or hotspot, and no VCEP domain table exists for this gene. |
cspec
final_classification_framework
spliceai
clinvar
PMID:25741868
|
| PM2 | Met | Met (supporting): gnomAD v4.1 total allele frequency 0.0000161 (26/1,613,178; grpmax FAF 0.0000138) is below the 0.0001 PM2 threshold. |
gnomad_v2
gnomad_v4
cspec
PMID:25741868
|
| PM3 | Not met | Not met: no trans-with-pathogenic RAD51C observation exists; all four ClinVar submitters report likely benign without any phasing evidence for this intronic variant. |
cspec
clinvar
PMID:25741868
|
| PM4 | N/A | Not applicable: c.571+15G>T is intronic with no protein-length change (p.?), so the PM4 in-frame indel/stop-loss requirement is not met. |
cspec
spliceai
PMID:25741868
|
| PM5 | N/A | Not applicable: c.571+15G>T alters no codon (p.?), so there is no residue at which a different pathogenic missense could be compared. |
pm5_candidates
cspec
PMID:25741868
|
| PM6 | Not assessed | Not assessed: no proband and no parental genotypes of any kind were reported, so no assumed de novo event could be evaluated. |
cspec
PMID:25741868
clinvar
|
| PP1 | Not assessed | Not assessed: zero family members or informative meioses are documented, so co-segregation with disease cannot be observed. |
cspec
PMID:25741868
clinvar
|
| PP2 | N/A | Not applicable: PP2 is restricted to missense variants, and c.571+15G>T is intronic with no amino-acid substitution (p.?). |
cspec
PMID:25741868
|
| PP3 | Not met | Not met: SpliceAI max delta 0.006 falls far below the >=0.2 supporting PP3 threshold. |
spliceai
cspec
|
| PP4 | Not assessed | Not assessed: no proband phenotype or family history is available to test specificity for RAD51C. |
clinvar
cspec
PMID:25741868
|
| PP5 | Not met | Not met: the exact-variant ClinVar record has four non-expert laboratory submissions and zero expert-panel assertions. |
clinvar
cspec
PMID:25741868
|
| BA1 | Not met | Not met: the highest observed allele frequency, 0.00018 in a small 'Remaining individuals' bin, is far below the 0.05 BA1 stand-alone threshold. |
gnomad_v2
gnomad_v4
cspec
PMID:25741868
|
| BS1 | Not met | Not met: dataset allele frequencies of 0.0000161 (gnomAD v4.1) and 0.0000203 (v3.1 non-cancer genomes) are far below the 0.01 BS1 threshold. |
gnomad_v2
gnomad_v4
cspec
|
| BS2 | Not met | Not met: only one homozygous adult is reported (gnomAD v4.1, 26/1,613,178 alleles) and RAD51C cancer risk is adult-onset with reduced penetrance, failing BS2's healthy-adult requirement. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| BS3 | Not assessed | Not assessed: no functional assay shows normal splicing or preserved RAD51C function for c.571+15G>T, so BS3 lacks its required supporting evidence. |
PMID:25741868
cspec
clinvar
|
| BS4 | Not assessed | Not assessed: no pedigree or relative genotypes exist, so non-segregation in a family cannot be demonstrated by any source. |
cspec
PMID:25741868
clinvar
|
| BP1 | N/A | Not applicable: BP1 is limited to missense variants, and c.571+15G>T is intronic with no amino-acid substitution (p.?). |
pvs1_gene_context
cspec
PMID:25741868
|
| BP2 | Not met | Not met: no cis/trans phase relationship with a pathogenic RAD51C variant exists; gnomAD v4.1's lone homozygote (26/1,613,178 alleles) is not trans-with-pathogenic evidence. |
cspec
clinvar
gnomad_v2
gnomad_v4
PMID:25741868
|
| BP3 | N/A | Not applicable: c.571+15G>T is a single-nucleotide intronic substitution (p.?), not an in-frame indel in a repeat region as BP3 requires. |
cspec
PMID:25741868
|
| BP4 | Met | Met (supporting): SpliceAI max delta 0.006 is below the <=0.1 BP4 supporting threshold. |
spliceai
cspec
|
| BP5 | Not assessed | Not assessed: no proband or case-level data exist to show an alternate molecular basis for disease. |
clinvar
cspec
PMID:25741868
|
| BP6 | Not met | Not met: ClinVar reports Likely benign from four non-expert laboratories, with no expert-panel assertion to trigger BP6. |
clinvar
cspec
PMID:25741868
|
| BP7 | N/A | Not applicable: c.571+15G>T is intronic, not a synonymous variant, so BP7's scope is not met. |
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.